Press Releases Keyword Search Year None20232022202120202019 Mar 29, 2023 CRISPR Therapeutics Announces Departure of Board Member Mar 27, 2023 CRISPR Therapeutics and Vertex Announce Licensing Agreement to Accelerate Development of Vertex’s Hypoimmune Cell Therapies for the Treatment of Type 1 Diabetes Mar 14, 2023 CRISPR Therapeutics to Present at the American Association for Cancer Research 2023 Annual Meeting Mar 13, 2023 CRISPR Therapeutics Announces Transition of Chief Financial Officer Feb 27, 2023 CRISPR Therapeutics to Participate in the 43rd Annual Cowen Health Care Conference Feb 21, 2023 CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results Feb 08, 2023 CRISPR Therapeutics to Participate in Upcoming Investor Conferences Jan 11, 2023 CRISPR Therapeutics to Participate in B. Riley Securities’ 3rd Annual Oncology Conference